MX9700157A - Proceso para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin -1-ona y producto intermediario. - Google Patents

Proceso para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin -1-ona y producto intermediario.

Info

Publication number
MX9700157A
MX9700157A MX9700157A MX9700157A MX9700157A MX 9700157 A MX9700157 A MX 9700157A MX 9700157 A MX9700157 A MX 9700157A MX 9700157 A MX9700157 A MX 9700157A MX 9700157 A MX9700157 A MX 9700157A
Authority
MX
Mexico
Prior art keywords
formula
compound
converting
acid addition
compounds
Prior art date
Application number
MX9700157A
Other languages
English (en)
Inventor
Charles Alois Dvorak
Bruce Andrew Kowalczyk
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23040964&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX9700157(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9700157A publication Critical patent/MX9700157A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La invencion se refiere a nuevos procesos para preparar compuestos de la formula (2) este proceso comprende (A) deshidratar los compuestos de la formula (3), o (B) separar el compuesto de la formula (2) en estereoisomeros individuales, o (C) convertir el compuesto de la formula (2) a una sal de adicion de ácidos farmacéuticamente aceptable, o (D) convertir una sal de adicion de ácidos del compuesto de la formula (2) en la forma no salina, y de los compuestos de la formula (1) dicho proceso comprende (A) y (B) deshidratar el compuesto de la formula (3) e hidrogenar este compuesto para dar una mezcla diastereomérica de 1, o (C) separar la mezcla diastereomérica en estereoisomeros individuales o mezclas de ellos, o (D) convertir el compuesto de la formula (1) a una sal de adicion de ácidos farmacéuticamente aceptable, o (E) convertir una sal de adicion de ácidos del compuesto de la formula (1) a la forma salina. La invencion también se refiere al compuesto de la formula (3) y a un proceso para prepararlo. Los compuestos de las formulas (2 y 1) son potentes antagonistas del receptor de 5-HT3 y son utiles para tratar una condicion elegida de vomito, un desorden gastrointestinal, estado de ansiedad/depresivo, y dolor.
MX9700157A 1994-07-08 1995-07-01 Proceso para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin -1-ona y producto intermediario. MX9700157A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/272,715 US5567818A (en) 1994-07-08 1994-07-08 Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
PCT/EP1995/002556 WO1996001824A1 (en) 1994-07-08 1995-07-01 Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product

Publications (1)

Publication Number Publication Date
MX9700157A true MX9700157A (es) 1997-04-30

Family

ID=23040964

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700157A MX9700157A (es) 1994-07-08 1995-07-01 Proceso para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin -1-ona y producto intermediario.

Country Status (16)

Country Link
US (1) US5567818A (es)
EP (1) EP0770077B1 (es)
JP (1) JP2898758B2 (es)
CN (1) CN1048727C (es)
AT (1) ATE205845T1 (es)
AU (1) AU2979995A (es)
BR (1) BR9508249A (es)
CL (2) CL2004001244A1 (es)
CY (1) CY2342B1 (es)
DE (1) DE69522808T2 (es)
DK (1) DK0770077T3 (es)
ES (1) ES2162929T3 (es)
FI (1) FI120198B (es)
MX (1) MX9700157A (es)
PT (1) PT770077E (es)
WO (1) WO1996001824A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522018A (en) 2000-04-20 2003-09-26 Masonite Corp Reverse molded fibreboard panel
JO2735B1 (en) * 2003-01-30 2013-09-15 هيلسين هيلث كير أس ايه. Liquid pharmaceutical formations of balloonosterone
US8598219B2 (en) 2003-01-30 2013-12-03 Helsinn Healthcare Sa Liquid pharmaceutical formulations of palonosetron
US8614225B2 (en) * 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
US7737280B2 (en) * 2006-10-23 2010-06-15 Sicor Inc. Processes for preparing palonosetron salts
JP2010512333A (ja) * 2006-12-07 2010-04-22 ヘルシン ヘルスケア ソシエテ アノニム 塩酸パロノセトロンの結晶及び非晶質形
WO2008146283A2 (en) * 2007-05-29 2008-12-04 Chemagis Ltd. Novel palonosetron salts and processes for preparation and purification thereof
WO2009010987A1 (en) * 2007-07-19 2009-01-22 Natco Pharma Limited An improved process for the preparation of pure palonosetron hydrochloride
AR069625A1 (es) * 2007-12-13 2010-02-03 Glenmark Generics Ltd Base libre de palonosetron y procedimiento para su preparacion
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2009136405A1 (en) * 2008-05-05 2009-11-12 Natco Pharma Limited High purity palonosetron base and its solid state characteristics
EP2364312A4 (en) * 2008-11-11 2012-05-02 Reddys Lab Ltd Dr SYNTHESIS OF CRYSTALLINE PALONOSETRON CHLORHYDRATE
CN101851233B (zh) * 2009-04-03 2013-03-06 四川滇虹医药开发有限公司 盐酸帕洛诺司琼和其前体化合物及制备
US20120267533A1 (en) 2009-06-30 2012-10-25 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011013095A1 (en) 2009-07-31 2011-02-03 Ranbaxy Laboratories Limited Processes for the preparation of palonosetron
JP2014070036A (ja) * 2012-09-28 2014-04-21 Mitsubishi Gas Chemical Co Inc １，８−テトラリンジカルボン酸無水物の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4007191A (en) * 1975-10-14 1977-02-08 E. R. Squibb & Sons, Inc. 2-(Piperidinyl or tetrahydropyridinyl)-alkyl)-2,3-dihydro-3-hydroxy-1H-benz(DE)isoquinolin-1-ones
PL166277B1 (pl) * 1989-11-28 1995-04-28 Syntex Inc Sposób wytwarzania nowych zwiazków trójpierscieniowych PL PL PL PL
US5202318A (en) * 1990-05-14 1993-04-13 Syntex (U.S.A.) Inc. Tricyclic compounds acting at serotonin receptor subtypes

Also Published As

Publication number Publication date
ES2162929T3 (es) 2002-01-16
EP0770077B1 (en) 2001-09-19
FI120198B (fi) 2009-07-31
DE69522808D1 (de) 2001-10-25
JP2898758B2 (ja) 1999-06-02
CN1048727C (zh) 2000-01-26
CN1152313A (zh) 1997-06-18
CL2004001244A1 (es) 2005-04-15
FI970068A (fi) 1997-01-07
EP0770077A1 (en) 1997-05-02
WO1996001824A1 (en) 1996-01-25
PT770077E (pt) 2002-02-28
DE69522808T2 (de) 2002-04-04
DK0770077T3 (da) 2002-01-14
CL2007001958A1 (es) 2008-02-22
BR9508249A (pt) 1998-01-06
CY2342B1 (en) 2004-02-06
US5567818A (en) 1996-10-22
AU2979995A (en) 1996-02-09
ATE205845T1 (de) 2001-10-15
FI970068A0 (fi) 1997-01-07
JPH09508645A (ja) 1997-09-02

Similar Documents

Publication Publication Date Title
MX9700157A (es) Proceso para la preparacion de 2-(1-azabiciclo(2.2.2)oct-3il)-2,4,5,6-tetrahidro-1h-benz(de)isoquinolin -1-ona y producto intermediario.
AU658898B2 (en) Substituted 3-aminoquinuclidines
DE60102160T3 (de) Von arylalkylaminen abgeleitete carbamate
EP0239309B1 (en) Oxadiazoles useful in the treatment of senile dementia
HU9802402D0 (en) 4-aryl-piperidine-derivatives and process for producing them
IE913396A1 (en) Fused ring analogs of nitrogen containing nonaromatic heterocycles
CS1091A3 (en) 3-aminopiperidine derivatives and method of their production
UA35564C2 (uk) Поліциклічні аміновмісні сполуки, що є антагоністами рецепторів нейрокінінів, їх фармацевтично прийнятні енантіомери, солі, n-оксиди і продукти кватернізації, спосіб їх отримання, проміжні сполуки і фармацевтична композиція
EP1448530A1 (de) Heteroarylcarbonsäureamide
EP1527073B1 (de) Benzothiophen-, benzofuran- und indolharnstoffe und deren verwendung als alpha7-achr agonisten
MXPA02011417A (es) 1-aminoalquil-lactamas sustituidas y su uso como antagonistas de receptores muscarinicos.
GR3024592T3 (en) Process for preparing and resolving 2-phenyl-3-aminopiperidine
US5716965A (en) Substituted 3-aminoquinuclidines
CA2192357A1 (en) Process for the preparation of 2-(1-azabicyclo(2.2.2)oct-3-yl) -2,4,5,6-tetrahydro-1h-benz(de)isoquinolin-1-one and intermediate product
EP3027606B1 (en) Compounds for enhancing the cognitive function
DE10334724A1 (de) N-Biarylamide
DE69821642T2 (de) Substituierte oxime als neurokinin antagonisten
EP0236263B1 (de) Substituierte Pyrrolidinone
AU605434B2 (en) Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
IE63420B1 (en) Azabicyclo amides and esters as 5-ht3 receptor antagonists
US5147873A (en) Amino-substituted bridged azabicyclic quinolone carboxylic acids and esters
DE19733439A1 (de) Neue 6-endo-Amino-3-azabicyclo(3.1.0)hexande, Verfahren zu deren Herstellung und deren Verwendung zur Herstellung von Chinolon- und Naphthyridincarbonsäure-Derviaten mit verbesserten Eigenschaften
EP0187122A2 (de) 1,3,4-Trisubstituierte Azacycloalkane bzw. Azacycloalkene
MY115259A (en) Process for the preparation of nmda antagonists
HU205756B (en) Process for producing quinolonecarboxylic acids substituted with azabicyclic group of bridged structure and substituted with amino group, as well as pharmaceutical compositions comprising same